Acta Scientific Otolaryngology (ASOL) (ISSN: 2582-5550)

Case Report Volume 5 Issue 3

Positron Emission Computerized Axial Tomography in Treatment Planning Radiant of Mediastinal Relapsed Hodgkin Lymphoma

Rubén Alexander Elzaurdín Mora1* and Noralys Lara Fernández2

1Specialist I Degree in Medical Oncology, Diploma in Oncological Radiotherapy, Medical-Surgical Research Center, Havana, Cuba
2Specialist I Degree in Medical Oncology, Miguel Enríquez Teaching General Hospital, Havana, Cuba

*Corresponding Author: Rubén Alexander Elzaurdín Mora, Specialist I Degree in Medical Oncology, Diploma in Oncological Radiotherapy, Medical-Surgical Research Center, Havana, Cuba.

Received: December 21, 2022; Published: February 20, 2023

Abstract

Introduction: Hodgkin's lymphoma is a lymphoproliferative process characterized by a polymorphous infiltrate containing Reed-Sternberg cells and various accessory populations. The treatment is high-efficiency chemotherapy. Some patients may need radiation therapy or, if the lymphoma recurs after primary treatment, high-dose chemoradiation therapy and autologous hematopoietic stem cell transplantation.

Objective: To demonstrate how the use of positron emission computed tomography (PET-CT) influenced the radiation treatment planning process in a patient diagnosed with mediastinal relapsed Hodgkin lymphoma.

Case presentation: A 24-year-old female patient diagnosed since February 2017 with Hodgkin's lymphoma, nodular sclerosis variety with extranodal extension. He was treated with polychemotherapy and achieved a total response. In January 2020, the presence of a mediastinal relapse of the disease was detected. The use of PET-CT allowed for better planning of ionizing radiation therapy. The process of delineating the volume to be treated, was carried out with greater accuracy, protecting vital organs of this region.

Conclusions: The use of PET-CT in the design of radiant treatment, allows more precise therapeutic plans achieving favorable objective responses in patients with mediastinal relapse of Hodgkin lymphoma. Its use reduces the volume to be irradiated and precisely delimits the risk organs to be protected during radiation therapy, achieving a response greater than 90% in combination with chemotherapy. These results increase the survival of our patients.

Keywords: Hodgkin's Lymphoma; Radiotherapy; Chemotherapy; Positron Emission Computed Tomography

References

  1. Pena Pereiro A and Fernández Esquivel A. “Hodgkin's disease. Diagnosis and treatment”. Revista Cubana de Medicina 6 (2020): [approx. 0 p.].
  2. Rosenberg SA. “Textbook of Medicine”. Bee- son-Mc. Dermott. California. 14 Ed. Saunders. (1975): 1509.
  3. Ministry of Public Health (MINSAP). Health Statistics Yearbook, 2015. The Havana: Directorate of Medical and Health Statistical Records; (2016): 103-104.
  4. Manz-KorholzCh., et al. “Pediatric Hodgkin lymphoma”. Journal of Clinical Oncology 33 (2015): 2986-2988.
  5. Narang A and Terezakis S. “Contemporary radiation therapy in combined modality therapy for Hodgkin lymphoma”. Journal of the National Comprehensive Cancer Network 13 (2015): 597-605.
  6. Hodgson D., et al. “Implementation of contemporary radiation therapy planning concepts for pediatric Hodgkin lymphoma: guidelines from the International Lymphoma Radiation Oncology Group”. Practical Radiation Oncology 5 (2015): 85-92.
  7. Alert Silva J and Chon Rivas I. “Assessment of radiant treatment in Hodgkin in children and adolescents”. Cuban Journal of Pediatrics3 (2017).
  8. Brice P. “Hodgkin's disease or lymphoma”. EMC - Treatise on Medicine 1 (2012): 1-5.
  9. Yung L and Linch D. “Hodgkin' s Lymphoma”. Lancet 36 (2003): 943-951.
  10. Metzger M., et al. “Lymphomas in children”. In: Pérez C, Brady L, Halperin E, Mazer D, eds. Principles and practice of Radiation Oncology. 6th Philadelphia: Lippincott, Williams and Wilkins (2013): 1695-712.
  11. Shankar A and Davis S. “Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents- a comprehensive review of biology, clinical course and treatment options”. British Journal of Haematology 159 (2015): 288-298.
  12. Bazz Ch., et al. “Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988-2005. An analysis of 21,734 cases”. Leuk Lymphoma 51 (2010): 2198-207.
  13. Soriano-Lorenzo J and Zaldívar-Blanco K. “Primary mediastinal large cell lymphoma B”. Revista de Hematología – Medigraphic 4 (2020): 225-235.

Citation

Citation: Rubén Alexander Elzaurdín Mora and Noralys Lara Fernández. “Positron Emission Computerized Axial Tomography in Treatment Planning Radiant of Mediastinal Relapsed Hodgkin Lymphoma".Acta Scientific Otolaryngology 5.3 (2023): 40-43.

Copyright

Copyright: © 2022 Rubén Alexander Elzaurdín Mora and Noralys Lara Fernández. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate34%
Acceptance to publication20-30 days
Impact Factor0.871

Indexed In







News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is November 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US